These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 10337069)
1. [Prevention of deep vein thrombosis (DVT) with the low molecular weight heparin (LMWH) and epidural/spinal anesthesia. The efficacy viewpoint]. Cyrkowicz A; Fiala J; Kacalski J; Jackowski P; Bielaszka K; Smida A Ginekol Pol; 1998 Nov; 69(11):795-9. PubMed ID: 10337069 [TBL] [Abstract][Full Text] [Related]
2. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of low molecular weight heparin. Gynecological ward retrospective analysis. Cyrkowicz A Eur J Obstet Gynecol Reprod Biol; 2002 Jan; 100(2):223-6. PubMed ID: 11750969 [TBL] [Abstract][Full Text] [Related]
3. [Spinal analgesia and perioperative low molecular weight heparin (LMWH) prophylaxis of thrombosis. Safety aspect]. Cyrkowicz A; Orczyk K; Bajorek M; Kawecki J; Jackowski P Ginekol Pol; 1997 Nov; 68(11):523-7. PubMed ID: 9770848 [TBL] [Abstract][Full Text] [Related]
4. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement. Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569 [TBL] [Abstract][Full Text] [Related]
5. The effects of location and low-molecular-weight heparin administration on deep vein thrombosis outcomes in trauma patients. Lee TH; Alonzo BJ; Differding J; Underwood SJ; Hamilton G; Kremenevskiy I; McNamara S; Schreiber MA J Trauma Acute Care Surg; 2013 Feb; 74(2):476-81. PubMed ID: 23354241 [TBL] [Abstract][Full Text] [Related]
6. A comparison of low molecular weight heparin and low dose unfractionated heparin prophylaxis in subacute myelopathy. Spivack SB; Aisen ML J Spinal Cord Med; 1997 Oct; 20(4):402-5. PubMed ID: 9360220 [TBL] [Abstract][Full Text] [Related]
7. Subcutaneous low-molecular weight heparin or oral anticoagulants for the prevention of deep-vein thrombosis in elective hip and knee replacement? Fraxiparine Oral Anticoagulant Study Group. Hamulyák K; Lensing AW; van der Meer J; Smid WM; van Ooy A; Hoek JA Thromb Haemost; 1995 Dec; 74(6):1428-31. PubMed ID: 8772214 [TBL] [Abstract][Full Text] [Related]
9. Prevention of deep venous thrombosis and pulmonary embolism in patients with acute intracerebral hemorrhage. Orken DN; Kenangil G; Ozkurt H; Guner C; Gundogdu L; Basak M; Forta H Neurologist; 2009 Nov; 15(6):329-31. PubMed ID: 19901711 [TBL] [Abstract][Full Text] [Related]
10. Prevention of deep vein thrombosis in patients with hip fractures: low molecular weight heparin versus dextran. Oertli D; Hess P; Durig M; Laffer U; Fridrich R; Jaeger K; Kaufmann R; Harder F World J Surg; 1992; 16(5):980-4; discussion 984-5. PubMed ID: 1281362 [TBL] [Abstract][Full Text] [Related]
11. Management of venous thromboembolic disease. The impact of low-molecular-weight heparin. Tapson VF; Hull RD Clin Chest Med; 1995 Jun; 16(2):281-94. PubMed ID: 7656540 [TBL] [Abstract][Full Text] [Related]
12. Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement. Bell GK; Goldhaber SZ Vasc Med; 2001; 6(1):23-9. PubMed ID: 11358156 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of a low molecular weight heparin administered intravenously or subcutaneously in comparison with intravenous unfractionated heparin in the treatment of deep venous thrombosis. Certoparin-Study Group. Kirchmaier CM; Wolf H; Schäfer H; Ehlers B; Breddin HK Int Angiol; 1998 Sep; 17(3):135-45. PubMed ID: 9821025 [TBL] [Abstract][Full Text] [Related]
14. Pregnancy after catheter-directed thrombolysis for acute iliofemoral deep venous thrombosis. Jørgensen M; Broholm R; Bækgaard N Phlebology; 2013 Mar; 28 Suppl 1():34-8. PubMed ID: 23482532 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological prophylaxis for deep vein thrombosis in acute spinal cord injury: an Indian perspective. Halim TA; Chhabra HS; Arora M; Kumar S Spinal Cord; 2014 Jul; 52(7):547-50. PubMed ID: 24819510 [TBL] [Abstract][Full Text] [Related]
16. Low molecular weight heparin versus acenocoumarol in the secondary prophylaxis of deep vein thrombosis. Lopaciuk S; Bielska-Falda H; Noszczyk W; Bielawiec M; Witkiewicz W; Filipecki S; Michalak J; Ciesielski L; Mackiewicz Z; Czestochowska E; Zawilska K; Cencora A Thromb Haemost; 1999 Jan; 81(1):26-31. PubMed ID: 9974369 [TBL] [Abstract][Full Text] [Related]
17. Home treatment of deep vein thrombosis: a two-years experience of a single institution. Grau E; Real E; Pastor E; Viciano V; Aguiló J Haematologica; 1998 May; 83(5):438-41. PubMed ID: 9658729 [TBL] [Abstract][Full Text] [Related]
18. [Clinical analysis of 20 pregnant women with venous thromboembolic disease]. Sun P; Dong DN Zhonghua Fu Chan Ke Za Zhi; 2011 Dec; 46(12):911-6. PubMed ID: 22333281 [TBL] [Abstract][Full Text] [Related]
19. A randomized trial comparing 2 low-molecular-weight heparins for the outpatient treatment of deep vein thrombosis and pulmonary embolism. Wells PS; Anderson DR; Rodger MA; Forgie MA; Florack P; Touchie D; Morrow B; Gray L; O'Rourke K; Wells G; Kovacs J; Kovacs MJ Arch Intern Med; 2005 Apr; 165(7):733-8. PubMed ID: 15824291 [TBL] [Abstract][Full Text] [Related]
20. Home therapy with LMWH in deep vein thrombosis: randomized study comparing single and double daily administrations. Bellosta R; Ferrari P; Luzzani L; Carugati C; Cossu L; Talarico M; Sarcina A Angiology; 2007; 58(3):316-22. PubMed ID: 17626986 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]